EBNA1 binding and epigenetic regulation of gastrokine tumor suppressor genes in gastric carcinoma cells

Virology Journal

Volumn 11, Issue 1, 2014, Pages

  Lu, Fang ^a   Tempera, Italo ^b   Lee, Hyunna T ^a   Dewispelaere, Karen ^a   Lieberman, Paul M ^a  

^a WISTAR INSTITUTE   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ChIP Seq; EBNA1; EBV; Epigenetic; Gastric carcinoma; Gastrokine

Indexed keywords

CARRIER PROTEINS; CELL LINE, TUMOR; EPIGENESIS, GENETIC; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; HUMANS; PEPTIDE HORMONES; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; TUMOR SUPPRESSOR PROTEINS;

EID: 84892700690     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-11-12     Document Type: Article

References (51)

1. Kieff E, Epstein-Barr virus and its replication Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins 5 2007
2. Rickinson AB, Kieff E, Epstein-Barr virus Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins 5 2007
3. Epstein-Barr virus and gastric carcinoma. Takada K, Mol Pathol 2000 53 255 261 10.1136/mp.53.5.255 11091849
4. Epstein-Barr virus-associated gastric carcinoma. Fukayama M, Ushiku T, Pathol Res Pract 2011 207 529 537 10.1016/j.prp.2011.07.004 21944426
5. Epstein-Barr virus and gastric carcinoma. Fukayama M, Pathol Int 2010 60 337 350 10.1111/j.1440-1827.2010.02533.x 20518883
6. Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein. Imai S, Koizumi S, Sugiura M, Tokunaga M, Uemura Y, Yamamoto N, Tanaka S, Sato E, Osato T, Proc Natl Acad Sci USA 1994 91 9131 9135 10.1073/pnas.91.19.9131 8090780
7. Epidemiology of upper gastrointestinal malignancies. Crew KD, Neugut AI, Semin Oncol 2004 31 450 464 10.1053/j.seminoncol.2004.04.021 15297938 (Pubitemid 39070265)
8. Unique transcription pattern of Epstein-Barr virus (EBV) in EBV-carrying gastric adenocarcinomas: expression of the transforming BARF1 gene. Zur Hausen A, Brink AA, Craanen ME, Middeldorp JM, Meijer CJ, van den Brule AJ, Cancer Res 2000 60 2745 2748 10825150 (Pubitemid 30318253)
9. Transcriptional analysis of Epstein-Barr virus gene expression in EBV-positive gastric carcinoma: unique viral latency in the tumour cells. Sugiura M, Imai S, Tokunaga M, Koizumi S, Uchizawa M, Okamoto K, Osato T, Br J Cancer 1996 74 625 631 10.1038/bjc.1996.412 8761381 (Pubitemid 26279061)
10. Expression of Epstein-Barr virus genes in EBV-associated gastric carcinomas. Luo B, Wang Y, Wang XF, Liang H, Yan LP, Huang BH, Zhao P, World J Gastroenterol 2005 11 629 633 15655811 (Pubitemid 40220748)
11. A naturally derived gastric cancer cell line shows latency I Epstein-Barr virus infection closely resembling EBV-associated gastric cancer. Oh ST, Seo JS, Moon UY, Kang KH, Shin DJ, Yoon SK, Kim WH, Park JG, Lee SK, Virology 2004 320 330 336 10.1016/j.virol.2003.12.005 15016554 (Pubitemid 38315158)
12. Potential cellular functions of Epstein-Barr Nuclear Antigen 1 (EBNA1) of Epstein-Barr virus. Smith DW, Sugden B, Viruses 2013 5 226 240 10.3390/v5010226 23325328
13. The plasmid replicon of Epstein-Barr virus: mechanistic insights into efficient, licensed, extrachromosomal replication in human cells. Lindner SE, Sugden B, Plasmid 2007 58 1 12 10.1016/j.plasmid.2007.01.003 17350094 (Pubitemid 46874590)
14. Contributions of Epstein-Barr nuclear antigen 1 (EBNA1) to cell immortalization and survival. Frappier L, Viruses 2012 4 1537 1547 10.3390/v4091537 23170171
15. Role of EBNA1 in NPC tumourigenesis. Frappier L, Semin Cancer Biol 2012 22 154 161 10.1016/j.semcancer.2011.12.002 22206863
16. Identifying sites bound by Epstein-Barr virus nuclear antigen 1 (EBNA1) in the human genome: defining a position-weighted matrix to predict sites bound by EBNA1 in viral genomes. Dresang LR, Vereide DT, Sugden B, J Virol 2009 83 2930 2940 10.1128/JVI.01974-08 19129441
17. Genome-wide analysis of host-chromosome binding sites for Epstein-Barr Virus Nuclear Antigen 1 (EBNA1). Lu F, Wikramasinghe P, Norseen J, Tsai K, Wang P, Showe L, Davuluri RV, Lieberman PM, Virol J 2010 7 262 10.1186/1743-422X-7- 262 20929547
18. EBV is necessary for proliferation of dually infected primary effusion lymphoma cells. Mack AA, Sugden B, Cancer Res 2008 68 6963 6968 10.1158/0008-5472.CAN-08-0627 18757410
19. The Epstein-Barr virus nuclear antigen-1 promotes genomic instability via induction of reactive oxygen species. Gruhne B, Sompallae R, Marescotti D, Kamranvar SA, Gastaldello S, Masucci MG, Proc Natl Acad Sci USA 2009 106 2313 2318 10.1073/pnas.0810619106 19139406
20. Decreased expression of gastrokine 1 and the trefoil factor interacting protein TFIZ1/GKN2 in gastric cancer: influence of tumor histology and relationship to prognosis. Moss SF, Lee JW, Sabo E, Rubin AK, Rommel J, Westley BR, May FE, Gao J, Meitner PA, Tavares R, Resnick MB, Clin Cancer Res 2008 14 4161 4167 10.1158/1078-0432.CCR-07-4381 18593995
21. Inactivation of the Gastrokine 1 gene in gastric adenomas and carcinomas. Yoon JH, Song JH, Zhang C, Jin M, Kang YH, Nam SW, Lee JY, Park WS, J Pathol 2011 223 618 625 10.1002/path.2838 21341273
22. Gastrokine 1 is abundantly and specifically expressed in superficial gastric epithelium, down-regulated in gastric carcinoma, and shows high evolutionary conservation. Oien KA, McGregor F, Butler S, Ferrier RK, Downie I, Bryce S, Burns S, Keith WN, J Pathol 2004 203 789 797 10.1002/path.1583 15221938 (Pubitemid 38961565)
23. Gastrokines: stomach-specific proteins with putative homeostatic and tumor suppressor roles. Menheniott TR, Kurklu B, Giraud AS, Am J Physiol Gastrointest Liver Physiol 2013 304 109 G121 10.1152/ajpgi.00374.2012 23154977
24. Role of trefoil factor 1 in gastric cancer and relationship between trefoil factor 1 and gastrokine 1. Mao W, Chen J, Peng TL, Yin XF, Chen LZ, Chen MH, Oncol Rep 2012 28 1257 1262 22842654
25. Downregulation of gastrokine-1 in gastric cancer tissues and restoration of its expression induced gastric cancer cells to apoptosis. Mao W, Chen J, Peng TL, Yin XF, Chen LZ, Chen MH, J Exp Clin Cancer Res 2012 31 49 10.1186/1756-9966-31-49 22621392
26. Gastrokine 1 functions as a tumor suppressor by inhibition of epithelial-mesenchymal transition in gastric cancers. Yoon JH, Kang YH, Choi YJ, Park IS, Nam SW, Lee JY, Lee YS, Park WS, J Cancer Res Clin Oncol 2011 137 1697 1704 10.1007/s00432-011-1051-8 21898090
27. Gastrokine 1 induces senescence through p16/Rb pathway activation in gastric cancer cells. Xing R, Li W, Cui J, Zhang J, Kang B, Wang Y, Wang Z, Liu S, Lu Y, Gut 2012 61 43 52 10.1136/gut.2010.230623 21676900
28. Proteomics characterization of gastrokine 1-induced growth inhibition of gastric cancer cells. Yan GR, Xu SH, Tan ZL, Yin XF, He QY, Proteomics 2011 11 3657 3664 10.1002/pmic.201100215 21751384
29. Infection of Epstein-Barr virus in a gastric carcinoma cell line induces anchorage independence and global changes in gene expression. Marquitz AR, Mathur A, Shair KH, Raab-Traub N, Proc Natl Acad Sci USA 2012 109 9593 9598 10.1073/pnas.1202910109 22647604
30. Expression of Epstein-Barr nuclear antigen 1 in gastric carcinoma cells is associated with enhanced tumorigenicity and reduced cisplatin sensitivity. Cheng TC, Hsieh SS, Hsu WL, Chen YF, Ho HH, Sheu LF, Int J Oncol 2010 36 151 160 19956844
31. Survival advantage of EBV-associated gastric carcinoma: survivin up-regulation by viral latent membrane protein 2A. Hino R, Uozaki H, Inoue Y, Shintani Y, Ushiku T, Sakatani T, Takada K, Fukayama M, Cancer Res 2008 68 1427 1435 10.1158/0008-5472.CAN-07-3027 18316606 (Pubitemid 351346850)
32. EBNA1 regulates cellular gene expression by binding cellular promoters. Canaan A, Haviv I, Urban AE, Schulz VP, Hartman S, Zhang Z, Palejev D, Deisseroth AB, Lacy J, Snyder M, et al. Proc Natl Acad Sci USA 2009 106 22421 22426 10.1073/pnas.0911676106 20080792
33. EBNA-1, a Bifunctional Transcriptional Activator. Kennedy G, Sugden B, Mol Cell Biol 2003 23 6901 6908 10.1128/MCB.23.19.6901-6908.2003 12972608 (Pubitemid 37214658)
34. Autorepression of Epstein-Barr virus nuclear antigen 1 expression by inhibition of pre-mRNA processing. Yoshioka M, Crum MM, Sample JT, J Virol 2008 82 1679 1687 10.1128/JVI.02142-07 18077719 (Pubitemid 351206919)
35. Transcriptional activation by EBV nuclear antigen 1 is essential for the expression of EBV's transforming genes. Altmann M, Pich D, Ruiss R, Wang J, Sugden B, Hammerschmidt W, Proc Natl Acad Sci USA 2006 103 14188 14193 10.1073/pnas.0605985103 16966603 (Pubitemid 44453001)
36. Promoter-proximal regulatory elements involved in oriP-EBNA1-independent and -dependent activation of the Epstein-Barr virus C promoter in B-lymphoid cell lines. Nilsson T, Zetterberg H, Wang YC, Rymo L, J Virol 2001 75 5796 5811 10.1128/JVI.75.13.5796-5811.2001 11390581 (Pubitemid 32553110)
37. E2F1, ARID3A/Bright and Oct-2 factors bind to the Epstein-Barr virus C promoter, EBNA1 and oriP, participating in long-distance promoter-enhancer interactions. Borestrom C, Forsman A, Ruetschi U, Rymo L, J Gen Virol 2012 93 1065 1075 10.1099/vir.0.038752-0 22302879
38. Transcription profiling of Epstein-Barr virus nuclear antigen (EBNA)-1 expressing cells suggests targeting of chromatin remodeling complexes. Sompallae R, Callegari S, Kamranvar SA, Masucci MG, PLoS One 2010 5 12052 10.1371/journal.pone.0012052 20706582
39. The importance of epigenetic alterations in the development of epstein-barr virus-related lymphomas. Takacs M, Segesdi J, Banati F, Koroknai A, Wolf H, Niller HH, Minarovits J, Mediterr J Hematol Infect Dis 2009 1 2009012 21416002
40. Epigenetic reprogramming of host genes in viral and microbial pathogenesis. Paschos K, Allday MJ, Trends Microbiol 2010 18 439 447 10.1016/j.tim.2010.07.003 20724161
41. Promoter hypermethylation of E-cadherin and its abnormal expression in Epstein-Barr virus-associated gastric carcinoma. Sudo M, Chong JM, Sakuma K, Ushiku T, Uozaki H, Nagai H, Funata N, Matsumoto Y, Fukayama M, International journal of cancer Journal international du cancer 2004 109 194 199 10.1002/ijc.11701 14750169 (Pubitemid 38240920)
42. High-density methylation of p14ARF and p16INK4A in Epstein-Barr virus-associated gastric carcinoma. Sakuma K, Chong JM, Sudo M, Ushiku T, Inoue Y, Shibahara J, Uozaki H, Nagai H, Fukayama M, International journal of cancer Journal international du cancer 2004 112 273 278 10.1002/ijc.20420 15352040 (Pubitemid 39244367)
43. Reduced expression and promoter methylation of p16 gene in Epstein-Barr virus-associated gastric carcinoma. Osawa T, Chong JM, Sudo M, Sakuma K, Uozaki H, Shibahara J, Nagai H, Funata N, Fukayama M, Jpn J Cancer Res 2002 93 1195 1200 10.1111/j.1349-7006.2002.tb01223.x 12460459 (Pubitemid 36032981)
44. Global and non-random CpG-island methylation in gastric carcinoma associated with Epstein-Barr virus. Chong JM, Sakuma K, Sudo M, Ushiku T, Uozaki H, Shibahara J, Nagai H, Funata N, Taniguchi H, Aburatani H, Fukayama M, Cancer Sci 2003 94 76 80 10.1111/j.1349-7006.2003.tb01355.x 12708478 (Pubitemid 36575862)
45. CpG island methylation status in gastric carcinoma with and without infection of Epstein-Barr virus. Chang MS, Uozaki H, Chong JM, Ushiku T, Sakuma K, Ishikawa S, Hino R, Barua RR, Iwasaki Y, Arai K, et al. Clin Cancer Res 2006 12 2995 3002 10.1158/1078-0432.CCR-05-1601 16707594 (Pubitemid 43837343)
46. Regulation of Epstein-Barr virus latency type by the chromatin boundary factor CTCF. Chau CM, Zhang XY, McMahon SB, Lieberman PM, J Virol 2006 80 5723 5732 10.1128/JVI.00025-06 16731911 (Pubitemid 43849150)
47. CTCF prevents the epigenetic drift of EBV latency promoter Qp. Tempera I, Wiedmer A, Dheekollu J, Lieberman PM, PLoS Pathog 2010 6 8 1001048 10.1371/journal.ppat.1001048 20730088
48. Cell-to-cell contact as an efficient mode of Epstein-Barr virus infection of diverse human epithelial cells. Imai S, Nishikawa J, Takada K, J Virol 1998 72 4371 4378 9557727 (Pubitemid 28188743)
49. Dynamic chromatin boundaries delineate a latency control region of Epstein-Barr virus. Chau CM, Lieberman PM, J Virol 2004 78 12308 12319 10.1128/JVI.78.22.12308-12319.2004 15507618 (Pubitemid 39458750)
50. Acetylation of the latency-associated nuclear antigen regulates repression of Kaposi's sarcoma-associated herpesvirus lytic transcription. Lu F, Day L, Gao SJ, Lieberman PM, J Virol 2006 80 5273 5282 10.1128/JVI.02541-05 16699007
51. Epigenetic regulation of Kaposi's sarcoma-associated herpesvirus latency by virus-encoded microRNAs that target Rta and the cellular Rbl2-DNMT pathway. Lu F, Stedman W, Yousef M, Renne R, Lieberman PM, J Virol 2010 84 2697 2706 10.1128/JVI.01997-09 20071580